Fig. 1.
Substitution of IIb amino acid residue D224 results in a loss of ligand binding function. FACS histograms depicting the binding of the IIbβ3complex-specific MoAb D57, the activation-independent ligand mimetic MoAb OPG2, or the ligand mimetic MoAb PAC1 to CHO cells transfected with wild-type IIbβ3 or IIbD224Vβ3. (A) MoAb D57 staining of cells transfected with IIbβ3 (shaded histogram) or IIbD224Vβ3 (open histogram). Untransfected CHO cells are depicted by the dotted histogram. (B) MoAb OPG2 staining of the IIbβ3 (shaded histogram) or IIbD224Vβ3 (open histogram) transfected cells. Untransfected CHO cells are depicted by the dotted histogram. Cells expressing wild-type IIbβ3 (C) or IIbD224Vβ3 (D) were activated by incubation with 4 μmol/L anti-LIBS6 for 30 minutes followed by the addition of MoAb PAC1 (IgM). Cells were washed, stained with fluorescein-conjugated goat antimouse IgM for 30 minutes, and analyzed by FACS. The binding of PAC1was analyzed in the presence (open histogram) and absence (shaded histogram) of the competitve inhibitor Ro43-5054.